Fortrea Holdings Inc. Announces Strategic Partnership with Omico

Market Activity

Fortrea (FTRE) closed the 24‑hour trading period ending 11:25 PM Central Europe on Friday, 23 November 2026, up 5.62 %. The current share price is USD 23.63 on major exchanges. The company’s share supply stands at 95.2 million, giving it a market capitalization of USD 2.3 billion. In the last 24 hours, approximately USD 59.6 million of Fortrea shares were traded.

Since the end of the previous month, Fortrea’s share price has risen 17.77 %. The 200‑day simple moving average is USD 15.48. The all‑time high for the past 52 weeks was USD 24.37 on 21 October 2026; the 52‑week low was USD 8.55 on 6 April 2026.

Recent Corporate Development

Fortrea Holdings Inc. has entered into a partnership with Australian precision‑oncology firm Omico. The collaboration aims to accelerate biomarker‑driven cancer trials by combining Omico’s patient‑matching platform and genomic profiling capabilities with Fortrea’s global clinical trial expertise. The joint effort will streamline investigator site selection, enhance patient recruitment, and expand access to biomarker‑matched studies, especially in Australia. The partnership is positioned to help sponsors identify suitable patient populations and plan more efficient trials. Fortrea’s experience across a broad range of therapeutic areas and Omico’s national precision‑oncology network are expected to improve the speed and precision of oncology drug development. This collaboration reflects the growing focus on precision medicine in the life‑sciences sector and highlights the companies’ commitment to facilitating rapid access to targeted therapies worldwide.

CompanyTickerDirectionCurrent Price (USD)Market Capitalisation (USD bn)
Peabody EnergyBTUDown 0.04 %22.892.7
AMC EntertainmentAMCDown 3.62 %2.902.7
Power IntegrationsPOWIDown 2.34 %46.982.7
Liberty EnergyLBRTDown 7.85 %15.592.7
MGE EnergyMGEEUp 3.10 %73.482.7

Additional details for selected companies:

  • AMC Entertainment Holdings: Announced that it will report its third‑quarter 2026 results on 4 November 2026 and will host an earnings webcast after market close. The company invites analysts and investors to submit questions in advance and will provide a recorded version on its website. No financial figures or performance commentary are included in the announcement.

  • Liberty Energy Inc.: Reported third‑quarter 2026 results, noting a rise in revenue and a transition from profit to a net loss. Management highlighted strengthened operational execution and modest price increases, while acknowledging drilling‑related delays and cost inflation as headwinds. The company confirmed a strategic partnership to deliver integrated power services to data‑center campuses and increased its quarterly cash dividend by 11 % to $0.10 per share, following a prior distribution of $0.09. The balance sheet remains solid, with cash and short‑term liquidity sufficient to support ongoing capital needs and a convertible note program. A conference call will be held on 22 October to discuss the results in detail.

  • Power Integrations: Current price‑to‑earnings ratio is 107.82.

  • Liberty Energy: Current price‑to‑earnings ratio is 22.67.

  • MGE Energy: Current price‑to‑earnings ratio is 17.70.

Company Overview

Fortrea Holdings Inc. operates as a healthcare sector holding company. Through its subsidiaries, it provides phase I to IV clinical trial management, clinical pharmacology, patient access solutions, and other enabling services. The company partners with emerging and large biopharma, medical device, and diagnostic firms to drive healthcare innovation globally. Fortrea is listed on the Nasdaq stock exchange and maintains an official website at www.fortrea.com .